Orbimed Advisors Llc Buys Bristol-Myers Squibb Company, ARMO BioSciences Inc, Tenet Healthcare Corp, Sells Eli Lilly and Co, Cigna Corp, Amgen Inc

• New Purchases: ARMO, THC, TORC, HCA, LPNT, TFX, ABT, MD, KTWO, GTS,
• Added Positions: BMY, MRK, DVA, UHS, AGN, JAZZ, ACAD, SHPG, ABBV, ALXN,
• Reduced Positions: CI, AMGN, LOXO, BGNE, BIIB, IMMU, CELG, ARRY, MGLN, GBT,
• Sold Out: LLY, ANTM, JUNO, AET, UNH, AGNPA.PFD, IART, DERM, ACHN, GKOS,

For the details of ORBIMED ADVISORS LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=ORBIMED+ADVISORS+LLC

1. Alexion Pharmaceuticals Inc (ALXN) - 3,268,275 shares, 4.55% of the total portfolio. Shares added by 13.50%
2. Regeneron Pharmaceuticals Inc (REGN) - 962,900 shares, 4.14% of the total portfolio. Shares added by 12.67%
3. Vertex Pharmaceuticals Inc (VRTX) - 1,854,600 shares, 3.78% of the total portfolio. Shares added by 6.51%
4. Merck & Co Inc (MRK) - 5,288,200 shares, 3.6% of the total portfolio. Shares added by 45.87%
5. Biogen Inc (BIIB) - 1,040,400 shares, 3.56% of the total portfolio. Shares reduced by 15.46%

Orbimed Advisors Llc initiated holding in ARMO BioSciences Inc. The purchase prices were between $29.74 and $54.34, with an estimated average price of $42.29. The stock is now traded at around $49.93. The impact to a portfolio due to this purchase was 1.93%. The holding were 4,118,903 shares as of 2018-03-31.

Orbimed Advisors Llc initiated holding in Tenet Healthcare Corp. The purchase prices were between $14.77 and $25.12, with an estimated average price of $19.91. The stock is now traded at around $33.70. The impact to a portfolio due to this purchase was 1.27%. The holding were 4,189,300 shares as of 2018-03-31.

Orbimed Advisors Llc initiated holding in HCA Healthcare Inc. The purchase prices were between $84.96 and $103.9, with an estimated average price of $97.03. The stock is now traded at around $103.60. The impact to a portfolio due to this purchase was 0.58%. The holding were 482,400 shares as of 2018-03-31.

Orbimed Advisors Llc initiated holding in resTORbio Inc. The purchase prices were between $9.58 and $20.85, with an estimated average price of $16.44. The stock is now traded at around $9.03. The impact to a portfolio due to this purchase was 0.58%. The holding were 4,830,387 shares as of 2018-03-31.

Orbimed Advisors Llc initiated holding in LifePoint Health Inc. The purchase prices were between $42.75 and $51.1, with an estimated average price of $48.11. The stock is now traded at around $53.35. The impact to a portfolio due to this purchase was 0.53%. The holding were 902,825 shares as of 2018-03-31.

Orbimed Advisors Llc initiated holding in Teleflex Inc. The purchase prices were between $242.67 and $287.65, with an estimated average price of $262.74. The stock is now traded at around $266.68. The impact to a portfolio due to this purchase was 0.37%. The holding were 117,000 shares as of 2018-03-31.

Orbimed Advisors Llc added to a holding in Bristol-Myers Squibb Company by 434.20%. The purchase prices were between $59.92 and $68.98, with an estimated average price of $64.33. The stock is now traded at around $52.69. The impact to a portfolio due to this purchase was 2.37%. The holding were 3,675,300 shares as of 2018-03-31.

Orbimed Advisors Llc added to a holding in Merck & Co Inc by 45.87%. The purchase prices were between $53.41 and $62.07, with an estimated average price of $56.63. The stock is now traded at around $59.13. The impact to a portfolio due to this purchase was 1.13%. The holding were 5,288,200 shares as of 2018-03-31.

Orbimed Advisors Llc added to a holding in DaVita Inc by 226.69%. The purchase prices were between $65 and $80.03, with an estimated average price of $73.45. The stock is now traded at around $68.09. The impact to a portfolio due to this purchase was 0.9%. The holding were 1,559,600 shares as of 2018-03-31.

Orbimed Advisors Llc added to a holding in Universal Health Services Inc by 342.16%. The purchase prices were between $110.15 and $127.27, with an estimated average price of $118.76. The stock is now traded at around $115.95. The impact to a portfolio due to this purchase was 0.88%. The holding were 772,900 shares as of 2018-03-31.

Orbimed Advisors Llc added to a holding in Allergan PLC by 141.43%. The purchase prices were between $144.02 and $188.15, with an estimated average price of $167.73. The stock is now traded at around $153.66. The impact to a portfolio due to this purchase was 0.86%. The holding were 693,605 shares as of 2018-03-31.

Orbimed Advisors Llc added to a holding in Jazz Pharmaceuticals PLC by 71.10%. The purchase prices were between $135.59 and $157.16, with an estimated average price of $146.69. The stock is now traded at around $163.58. The impact to a portfolio due to this purchase was 0.81%. The holding were 1,040,100 shares as of 2018-03-31.

Orbimed Advisors Llc sold out a holding in Eli Lilly and Co. The sale prices were between $74.21 and $87.6, with an estimated average price of $80.64.

Orbimed Advisors Llc sold out a holding in Anthem Inc. The sale prices were between $215.63 and $258.19, with an estimated average price of $234.91.

Orbimed Advisors Llc sold out a holding in Juno Therapeutics Inc. The sale prices were between $45.6 and $86.96, with an estimated average price of $77.77.

Orbimed Advisors Llc sold out a holding in Aetna Inc. The sale prices were between $168.11 and $193.74, with an estimated average price of $179.7.

Orbimed Advisors Llc sold out a holding in UnitedHealth Group Inc. The sale prices were between $212.55 and $248.47, with an estimated average price of $228.4.

Orbimed Advisors Llc sold out a holding in Allergan PLC. The sale prices were between $543.5 and $674.47, with an estimated average price of $612.79.